Literature DB >> 2542245

Identification of the types of insulin-like growth factor-binding proteins that are secreted by muscle cells in vitro.

R H McCusker1, C Camacho-Hübner, D R Clemmons.   

Abstract

We have previously shown that muscle cells secrete insulin-like growth factor-binding proteins. In the present study, BC3H-1 cells were shown to secrete one binding protein of Mr 32,000, whereas L6 cells secreted two binding proteins of Mr 31,000 and 24,000, as determined by ligand blotting. Subconfluent proliferating L6 cells secrete more of the Mr 24,000 binding protein, relative to the Mr 31,000 form. In contrast, differentiated L6 myotubes secreted similar quantities of the two forms. Insulin-like growth factor I preferentially stimulated secretion of the Mr 31,000 versus the Mr 24,000 binding protein from L6 cells and caused an increase in the secretion of the Mr 32,000 binding protein from BC3H-1 cells. The Mr 31,000 binding protein from L6 cells had a greater affinity for insulin-like growth factor II compared with insulin-like growth factor I, as did the Mr 32,000 binding protein of BC3H-1 cells. In contrast, the Mr 24,000 binding protein of L6 cells preferred insulin-like growth factor I. Neither porcine insulin nor relaxin competed for 125I-IGF-I binding. In conclusion, these muscle cell lines secrete only one or two forms of insulin-like growth factor-binding proteins. L6 cell differentiation is associated with a relative increase in the secretion of the Mr 31,000 binding protein compared with the Mr 24,000 form. Insulin-like growth factor I stimulates the secretion of its own binding proteins from muscle cells, and this may be an important mechanism for modulating cellular responsiveness to this growth factor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542245

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Glucocorticoids regulate the secretion of a 21kDa-IGF-binding protein by sheep adipose tissue explants.

Authors:  J Beattie; R G Vernon
Journal:  Mol Cell Biochem       Date:  1995-04-26       Impact factor: 3.396

2.  Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I.

Authors:  A Musarò; N Rosenthal
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  A unique receptor-independent mechanism by which insulinlike growth factor I regulates the availability of insulinlike growth factor binding proteins in normal and transformed human fibroblasts.

Authors:  C A Conover
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

4.  Role of insulin-like growth factors and myogenin in the altered program of proliferation and differentiation in the NFB4 mutant muscle cell line.

Authors:  D D Sarbassov; R Stefanova; V G Grigoriev; C A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

5.  Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.

Authors:  F Giorgino; R J Smith
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

6.  Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II.

Authors:  S M Rosenthal; A Brunetti; E J Brown; P W Mamula; I D Goldfine
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

7.  Zinc alters the kinetics of IGF-II binding to cell surface receptors and binding proteins.

Authors:  Robert H McCusker; Rebecca L Mateski; Jan Novakofski
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.925

8.  Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4.

Authors:  P Caroni; C Schneider; M C Kiefer; J Zapf
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.